Energize
Powering the mitochondrial system.
Mitochondrial Energetics and Metabolic Capacity
How do cells sustain energetic output and metabolic efficiency over time?
The Energize phase organizes literature investigating mitochondrial biogenesis, NAD+ metabolism, and metabolic stress response.
Pathways examined include AMPK signaling, oxidative phosphorylation efficiency, and mitochondrial-derived peptide regulation.
Reference literature is drawn from longevity research, exercise physiology, and metabolic biology.
- MOTS-c
Mitochondrial-derived peptide studied in metabolic homeostasis and energy-regulation research.
- NAD+
Investigated in mitochondrial function, sirtuin activity, and cellular energy literature.
- SS-31 (Elamipretide)
Mitochondria-targeted peptide investigated for cardiolipin stabilization and electron-transport research.
| Short Trial | Standard Trial | Extended Trial | |
|---|---|---|---|
| Research Period | 2 weeks | 4 weeks | 8 weeks |
| Research Schedule | 3 × weekly | 3 × weekly | Twice weekly |
| Research Dose | 50 mg (80 units) | 100 mg (160 units) | 100 mg (160 units) |
| Total Research Material | 500 mg (800 units) | 1500 mg (2400 units) | 2000 mg (3200 units) |
| Research Vials Needed | 1 × 500 mg vial | 3 × 500 mg vial | 4 × 500 mg vial |
Standardized educational reference: 500 mg NAD+ vial reconstituted with 8 mL bacteriostatic water (62.5 mg per mL; 0.625 mg per unit on a 100-unit insulin reference scale).
Research Note: Published mitochondrial-peptide trials are predominantly preclinical, with selected human studies conducted in defined patient populations.
With energetic capacity addressed, the literature progresses to somatotropic signaling and longer-arc physiological optimization.
For Research Use Only
Not for Human Consumption.
Describe. Never Prescribe.